TipRanks
Daewoong Pharmaceutical Co., Ltd. (KR:069620)
:069620
South Korea Market
069620
Daewoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see KR:069620 full AI Analyst Report?

Daewoong Pharmaceutical Co., Ltd. (069620) Balance Sheet

― Followers

Daewoong Pharmaceutical Co., Ltd. Balance Sheet

Daewoong Pharmaceutical Co., Ltd.'s total assets for Q2 2026 were ₩2.54T, an increase of 3.56% from the previous quarter. KR:069620 total liabilities were ₩1.35T for the fiscal quarter, a 3.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
₩ 2.36T₩ 1.98T₩ 1.77T₩ 1.56T₩ 1.42T
Total Liabilities
₩ 1.23T₩ 1.05T₩ 858.03B₩ 822.12B₩ 712.77B
Total Equity Gross Minority
₩ 1.13T₩ 926.98B₩ 912.28B₩ 741.22B₩ 702.41B
Other Metrics
Currency in KRW

Daewoong Pharmaceutical Co., Ltd. Debt to Assets